NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

Thanks Diver, but in the past I believe they used ASCO to appear at the Expert's Forum, not in making peer reviewed presentations. I don't know that the virtual ASCO is lowering attendance, though it may be. My Dr. personally would rather not attend, but liked to attend the virtual presentation.

While no one can be certain of a presentation there until one is announced, if it is, I believe it will have far greater impact than in the past as it will be the unveiling of a trial that's run for over a decade for peer review, not merely the Expert's Forum, which frankly is mostly intended for investors after the fact.

I suspect that by the time of SNO and AACR/EORTC we may be doing live, or hybrid sort of conferences, but certainly hope that we'll not wait that long for initial peer review. A journal publication would surely get the job done, the question is, would it preclude a presentation at any major conference because what's being presented is known. I do believe in the advantage of hearing from those who've actually done the work, and be able to question them, something which can't be done in a Journal. I believe it possible to leave out something from the Journal presentation that could be a part of a future conference presentation.

I frankly believe that Dr. Liau and others will speak at many smaller conferences, even thought much they present will have previously been presented elsewhere. Why? Because many will want to hear from those who've done the work, and to be able to speak with them directly, and ask questions. I would hope that if an ASCO presentation is made, a virtual Q & A would follow the formal presentation. All these things should be resolved in the next few weeks.

Gary